维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

19篇 您的检索式：作者名="Bacanli"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease显示文摘	Coskun M Bacanli A Sallakci N	2005	Experimental Dermatology2005，14，2：	1
	2	Adaptive neuro-fuzzy inference system for drought forecasting 显示文摘	BACANLI U G FIRAT M DIKBAS F	2009	Stochastic Environmental Research and Risk Assessment2009，23，：	1
	3	Comparison of the Full Outline of Unresponsiveness Score Coma Scale and the Glasgow Coma Scale in an emergency setting population 显示文摘	Eken C Karia] M Bacanli A	2009	Eur J Emerg Med2009，16，1：	1
	4	Adaptive neuro-fuzzy inference system for drought forecasting显示文摘	BACANLI U G FIRAT M DIKBAS F	2009	Stochastic Envi- ronmental Research and Risk Assessment2009，23，：	1
	5	Comparison of the full outline of unresponsiveness score coma scale and the Glasgow coma scale in an emergency setting population显示文摘	Eken C Kartal M Bacanli A		0，，01：	1
	6	Anxiety and depressive disorders in patients presenting with chest pain to the emergency department:a comparison between cardiac and non-cardiac origin显示文摘	Eken C Oktay C Bacanli A	2010	J Emerg Med2010，39，2：	1
	7	Anxiety and depressive disorder sin patients presenting with chest pain to the emergency department A comparison between cardiac and noncardiac origin显示文摘	Eken C Oktay C Bacanli A	2010	J Emerg Med2010，39，2：	1
	8	Review of the chronology of clinical manifestations in 60 patients with Behcet's disease显示文摘	Alpsoy E Donmez L Bacanli A	2003	Dermatology2003，207，4：	1
	9	Anxiety and depressive disorders in patients presenting with chest pain to the emergency department A comparison between cardiac and noncardiac origin显示文摘	Eken C Oktay C Bacanli A		0，，02：	1
	10	Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease显示文摘	Coskun M Bacanli A SaUakci N Alpsoy E Yavuzer U Yegin O	2005	Exp Dermatol2005，14，2：	1
	11	The protective role of ferulic acid on sepsis-induced oxidative damage in Wistar albi- no rats显示文摘	BACANLI M AYDIN S TANER G	2014	Environ Toxicol Pharmacol2014，38，3：	1
	12	CTLA-4 gene 49A/G polymorphism in Turkish patients with Behet's disease显示文摘	Sallakci N Bacanli A Coskun M	2005	Clin Exp Dermatol2005，30，5：	1
	13	Anxiety and depressive disorders in patients pressenting with chest pain to the emergency department: a com- parison between cardiac and non-cardiac cfigin显示文摘	Eken C Oktay C Bacanli A	2010	J Emerg Med2010，39，2：	1
	14	Specific interleukin-1 gene polymorphisms in Turkish patients with Beh(c)et 's disease显示文摘	Coskun M Bacanli A Sallakci N	2005	Exp Dermatol2005，14，：	1
	15	Anxiety and depressive disorders in patients pressenting with chest pain to the emer- gency department~ a com-parison between cardiac and non- cardiac origin显示文摘	Eken C Oktay C Bacanli A	2010	J EmergMed2010，39，2：	1
	16	Comparison of the Full Outline of Unresponsiveness Score Coma Scale and the Glasgow Coma Scale in an emergency setting population 显示文摘	Eken C Kartal M Bacanli A	2009	Eur J Emerg Med2009，16，1：	1
	17	外用粒细胞集落刺激因子治疗Behet病患者的口腔和生殖器溃疡显示文摘Background: Recurrent and painful ulcers of the oral mucosa and genital skin/mucosa are the most commonly observedmanifestations in patients with disease (BD). They affect patients’quality of life. Because of the effectiveness of granulocyte colony-stimulating factor (G-CSF) in wound healing, it may also be useful for the treatment of oral ulcers (OU) and genital ulcers (GU) of BD. Objective: We aimed to determine the efficacy of topically applied G-CSF in the treatment of OU and GU of BD. Methods: Seven patients with BD diagnosed according to the criteria of the International Study Group for Disease were involved in the study. The patients were observed for 3months before the study,and all occurrences were recorded during this period. Patients were given topical G-CSF for OU (4 ×120 μg/day, for 5 days) and/or GU (4 ×30 μg/day, for 5 days) and followed-up for 3 months after treatment. No concurrent disease-specific or immunosuppressive topical or systemic drugs were given during the study period. Results: G-CSF treatment decreased the healing time and pain of OU and GU in six of seven patients comparedwith the pretreatment period. However, the effectiveness of the G-CSF treatment on OU and GU healing time and pain severity did not continue during the post-treatment period. Conclusions: G-CSF has beneficial effects on the healing duration and pain severity of OU and GU of patients with BD. However, given the high cost, impractical preparation and inability to cure the disease, G-CSF treatment should be chosen only in selected patients.	Bacanli A. Yerebakan Dicle O. Parmaksizoglu B. E. Yilmaz 李政霄	2006	世界核心医学期刊文摘(皮肤病学分册)2006，，12：	0
	18	土耳其Behet病患者Toll样受体2 Arg753Gln基因的多态性	Bacanli A. Sallakci N. Yavuzer U. E.Alpsoy 任建文	2006	世界核心医学期刊文摘(皮肤病学分册)2006，0，10：	0
	19	土耳其白塞病患者CTLA-4基因的49A/G多态性	Sallakci N Bacanli A Coskun M. E. Alpsoy 潘敏	2005	世界核心医学期刊文摘(皮肤病学分册)2005，0，10：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费